| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR34A |
|
microRNA 34a
|
|
|
0.421 |
0.846 |
| POU5F1P3 |
|
POU class 5 homeobox 1 pseudogene 3
|
|
|
0.452 |
0.808 |
| POU5F1P4 |
|
POU class 5 homeobox 1 pseudogene 4
|
|
|
0.452 |
0.808 |
| MIR122 |
|
microRNA 122
|
|
|
0.468 |
0.808 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| GGTLC5P |
|
gamma-glutamyltransferase light chain 5 pseudogene
|
|
|
0.513 |
0.846 |
| GGTLC4P |
|
gamma-glutamyltransferase light chain 4 pseudogene
|
|
|
0.513 |
0.846 |
| LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
| MIR200A |
|
microRNA 200a
|
|
|
0.519 |
0.808 |
| LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
| MIR212 |
|
microRNA 212
|
|
|
0.535 |
0.808 |
| LOC102724197 |
|
inactive glutathione hydrolase 2
|
|
|
0.559 |
0.731 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| RNU1-1 |
|
RNA, U1 small nuclear 1
|
|
|
0.608 |
0.731 |
| AMCN |
|
arthrogryposis multiplex congenita, neurogenic
|
|
|
0.682 |
0.615 |
| PBC2 |
|
Biliary cirrhosis, primary, 2
|
|
|
0.931 |
0.192 |
| AKR1B1P2 |
|
aldo-keto reductase family 1 member B1 pseudogene 2
|
|
|
1.000 |
0.154 |
| POTEF |
A5A3E0
|
POTE ankyrin domain family member F
|
|
5.5E-06 |
0.481 |
0.885 |
| GGTLC3 |
B5MD39
|
gamma-glutamyltransferase light chain family member 3
|
|
|
0.513 |
0.846 |
| TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| CCL22 |
O00626
|
C-C motif chemokine ligand 22
|
Signaling
|
8.4E-03 |
0.500 |
0.846 |